Release Date: 27/11/17 09:34 Summary: Updated forbearance agreement with Noteholders Price Sensitive: No Download Document 181.94KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%